Generic Adderall XR 20 mg

Adderall XR 20 mg: Adult and Adolescent ADHD Treatment, Monitoring, and Prescription Safety

Adderall XR 20 mg is a once-daily extended-release mixed amphetamine salts capsule approved for attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients age 6 years and older. Under current FDA labeling, 20 mg per day is the recommended dose for adults starting treatment or switching from another medication. For adolescents ages 13 to 17 who begin at 10 mg, a clinician may increase to 20 mg after one week when symptoms remain inadequately controlled. These are prescribing-label facts, not instructions to self-start or increase a dose.

The 20 mg strength sits at an important decision point: expected benefit must be matched by acceptable sleep, appetite, growth, cardiovascular, psychiatric, and misuse outcomes. This guide uses a “treatment dashboard” approach so patients and caregivers can understand what should be monitored before, during, and after an Adderall XR 20 mg prescription. A qualified prescriber must make every individual treatment decision.

Safety Dashboard: Boxed Warning for Abuse, Misuse, and Addiction

Adderall XR has a high potential for abuse and misuse, and either can lead to a substance use disorder, including addiction. Misuse and abuse of CNS stimulants can cause overdose and death. Risk rises with higher doses and with unapproved administration such as snorting or injecting.

The prescriber should assess risk before treatment and repeatedly during treatment. Patients and families should receive clear information on proper use, locked storage, and disposal. The medication must never be shared. Adderall XR contains amphetamine and is a Schedule II controlled substance, so it requires a valid prescription and lawful dispensing by a licensed pharmacy.

Essential controls include:

• one patient, one current prescription, and one clear administration plan;
• no unsanctioned extra doses, bead splitting, crushing, or route alteration;
• no use for exams, weight loss, recreation, overnight work, or athletic performance;
• locked storage and awareness of the remaining quantity;
• prompt discussion of craving, overuse, early depletion, diversion pressure, or loss of control.

Product Dashboard: What the 20 mg Capsule Contains

Adderall XR combines four salts in equal amounts by weight: dextroamphetamine sulfate, amphetamine sulfate, dextroamphetamine saccharate, and amphetamine aspartate monohydrate. Each capsule contains immediate-release and delayed-release beads, creating a two-phase release pattern that extends delivery compared with immediate-release Adderall.

The 20 mg strength refers to the labeled mixed amphetamine salts in the entire extended-release capsule. It does not guarantee a 20-hour effect and cannot be compared directly with 20 mg of another stimulant. Methylphenidate, lisdexamfetamine, amphetamine oral suspension, immediate-release tablets, and other extended-release products have different release designs and conversion considerations.

Current branded labeling identifies the 20 mg capsule as orange/orange and imprinted “ADDERALL XR 20 mg.” Generic equivalents can have different colors, shells, and imprints. Confirm a changed appearance with the pharmacist before use. Color by itself cannot establish identity or authenticity.

Indication Dashboard: What Successful ADHD Treatment Means

ADHD is diagnosed from a comprehensive clinical evaluation, not from a short period of poor concentration or a positive response to a stimulant. Symptoms must form a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. Sleep deprivation, anxiety, depression, trauma, substance use, learning disorders, thyroid disease, medication effects, and other conditions can resemble or worsen ADHD.

Adderall XR is used as part of a treatment program that may also include behavioral strategies, education, counseling, organizational support, parent training, workplace or school accommodations, and care for coexisting conditions. The aim is not artificial euphoria or limitless productivity. Appropriate benefit is a realistic improvement in ADHD-related function without disproportionate harm.

Useful adult goals might involve completing essential work steps, reducing impulsive decisions, managing appointments, listening through conversations, or driving more safely. Adolescent goals might include turning in assignments, reducing classroom disruption, following routines, and improving safe decision-making. The goals should be chosen before dose evaluation.

Prescribing Dashboard: How 20 mg Fits Current Labeling

For adults with ADHD who are starting treatment or switching from another medication, the current FDA label recommends 20 mg per day. In adolescents ages 13 to 17, treatment generally begins at 10 mg per day, and the dose may be increased to 20 mg after one week when symptoms are not adequately controlled. For children ages 6 to 12, starting and adjustment recommendations differ, and the maximum recommended dose is 30 mg per day.

A labeled recommended dose is still not automatic. The prescriber should use the lowest effective dose and individualize treatment. An adult with severe renal impairment has a lower labeled recommendation, and Adderall XR is not recommended in end-stage renal disease. A younger patient, a stimulant-sensitive patient, or someone with significant side effects may need a different plan.

Never move to 20 mg because an online description says it is “stronger,” because another person takes it, or because 10 mg did not produce immediate results. The decision should be based on verified adherence, target-function data, tolerability, and medical review.

Pretreatment Dashboard: Cardiac, Psychiatric, and Neurologic Screening

Before treatment, current labeling directs clinicians to assess for cardiac disease through personal history, family history of sudden death or ventricular arrhythmia, and physical examination. Patients should also be clinically evaluated for motor or verbal tics and Tourette’s syndrome. Blood pressure and pulse require baseline and follow-up measurement.

Tell the prescriber about:

• structural heart defects, cardiomyopathy, coronary artery disease, arrhythmia, high blood pressure, fainting, chest pain, or exercise-related symptoms;
• a family history of sudden unexplained death or dangerous rhythm disorders;
• psychosis, hallucinations, mania, bipolar disorder, depression, suicidal thinking, aggression, or serious anxiety;
• seizure, abnormal EEG, motor or vocal tics, or Tourette’s syndrome;
• numb, cold, painful, color-changing, or wounded fingers or toes;
• kidney impairment;
• pregnancy, plans for pregnancy, or breastfeeding;
• stimulant misuse, alcohol or drug problems, addiction history, or diversion concerns;
• all prescription drugs, over-the-counter products, vitamins, supplements, caffeine, nicotine, cannabis, and recently stopped medicines.

Contraindication Dashboard: When Adderall XR Must Not Be Used

Adderall XR is contraindicated in patients with known hypersensitivity to amphetamine or another capsule component. It is also contraindicated during monoamine oxidase inhibitor treatment and for 14 days after stopping an MAOI. The group includes certain antidepressants and may include linezolid or intravenous methylene blue. The interaction can trigger a hypertensive crisis with stroke, heart attack, organ injury, or death.

FDA labeling advises avoiding Adderall XR in patients with structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmia, coronary artery disease, or other serious cardiac disease. Other health findings may also change the risk-benefit decision. A product page cannot clear a patient for treatment.

Administration Dashboard: The Correct Morning Method

Take Adderall XR once in the morning upon awakening, exactly as written on the pharmacy label. It may be taken with or without food. Avoid afternoon dosing because of the potential for insomnia.

The capsule can be swallowed whole. If it cannot be swallowed, open the capsule and sprinkle all beads onto applesauce. Consume the entire mixture immediately without chewing and do not store it. Never divide the capsule contents. Partial bead counts do not provide a reliable lower dose and can disrupt the prescribed extended-release pattern.

1. Confirm the patient name, 20 mg strength, and “extended-release” designation.
2. Take the medicine at the consistent, prescribed morning time.
3. Document administration when caregivers share responsibility.
4. Do not take another capsule because the expected effect is not immediately felt.
5. If the dose is missed, do not double the next dose or take it late without pharmacist advice.

Do not crush, chew, dissolve, snort, or inject the beads. These actions are misuse and can increase overdose and death risk.

Daily Function Dashboard: Measure More Than “Focus”

Medication review should use observable, repeated outcomes. Choose two or three important tasks and rate them before and during treatment. Consider accuracy, completion, prompts needed, impulsive errors, interruptions, and safe behavior. Avoid treating normal boredom or every unfinished task as medication failure.

For each day, note:

• dose and breakfast time;
• morning task initiation and organization;
• midday persistence and impulse control;
• late-day function as the effect changes;
• appetite and meals;
• headache, dry mouth, stomach symptoms, anxiety, or palpitations;
• bedtime, sleep onset, and total sleep.

Review data over several ordinary days. An exam day, deadline, conflict, illness, skipped meal, or short night may distort the apparent response. If function improves only by sacrificing sleep or nutrition, the dose may not represent a good fit.

Cardiovascular Dashboard: Pulse, Blood Pressure, and Symptoms

Stimulants may raise blood pressure and heart rate. FDA labeling describes average increases of about 2 to 4 mmHg in blood pressure and 3 to 6 beats per minute in pulse, with some patients experiencing larger changes. The prescriber should monitor hypertension and tachycardia.

Take home measurements only as instructed, using a suitable cuff after quiet rest. Record the number, time, symptoms, and whether caffeine, nicotine, exercise, decongestants, or another stimulant was involved. Do not add extra blood-pressure medicine or skip random stimulant doses to correct a reading.

Call the clinician for repeated racing heart, palpitations, marked increases, or reduced exercise tolerance. Seek emergency care for chest pain, fainting, severe shortness of breath, or signs of a serious cardiac event.

Nutrition Dashboard: Appetite, Weight, and Growth

Loss of appetite and weight loss are common stimulant-related concerns. Pediatric patients may have slowing of height or weight gain, so growth should be monitored. The clinician may interrupt treatment when a child is not growing as expected.

Record appetite across the whole day, not only at lunch. Discuss breakfast before the morning dose, nutrient-dense food when appetite is better, hydration, and an age-appropriate plan with the healthcare professional. Do not add unverified weight-gain supplements or use the stimulant for intentional weight loss.

Report rapid weight change, restrictive eating, dizziness, dehydration, fainting, persistent nausea, or inability to maintain nutrition. In an adolescent or adult with an eating disorder or body-image concerns, the prescriber needs complete information because appetite suppression can be misused.

Sleep Dashboard: Timing, Insomnia, and Rebound-Like Symptoms

Take the capsule upon awakening and avoid late administration. Track sleep opportunity, time to fall asleep, night waking, total sleep, and morning fatigue. Caffeine, energy drinks, nicotine, screens, anxiety, and inconsistent schedules can compound stimulant-related insomnia.

Late-day irritability or poor concentration may reflect fading medication effect, hunger, accumulated demands, or inadequate sleep. Do not assume it always requires a higher dose. A clinician can distinguish duration problems from side effects or another condition.

Never use alcohol, cannabis, a benzodiazepine, or someone else’s sleeping pill to counter Adderall XR. Sedating products can create new impairment, interactions, dependence, or unsafe driving.

Mental-Health Dashboard: Mood, Psychosis, and Mania

Stimulants can worsen symptoms in people with pre-existing psychosis and may induce a manic or mixed episode in patients at risk for bipolar disorder. New psychotic or manic symptoms have occurred at recommended doses in people without prior psychosis.

Report severe anxiety, emotional blunting, extreme irritability, aggression, euphoria, depression, unusual suspicion, or social withdrawal. New hallucinations, delusions, mania, or suicidal thoughts require immediate clinical attention. Call emergency services if the person may harm themselves or others or cannot be kept safe.

Neurologic and Circulation Dashboard

Adderall XR may lower seizure threshold in susceptible patients. A seizure requires urgent evaluation. Motor or vocal tics can appear or worsen; tell the prescriber rather than hiding symptoms to preserve a dose.

Peripheral vasculopathy, including Raynaud’s phenomenon, can cause fingers or toes to feel numb, cool, painful, or sensitive to temperature and to change color. Report these changes. Unexplained wounds or tissue breakdown on a finger or toe need immediate medical attention.

Interaction Dashboard: Medicines, Supplements, and Substances

MAO inhibitors

Do not take Adderall XR with an MAOI or within 14 days after stopping one. Always mention the stimulant before receiving linezolid, intravenous methylene blue, or emergency treatment.

Serotonergic medicines and CYP2D6 inhibitors

SSRIs, SNRIs, triptans, tricyclic antidepressants, lithium, tramadol, fentanyl, buspirone, tryptophan, St. John’s wort, and other serotonergic products can increase serotonin-syndrome risk. Some CYP2D6 inhibitors can raise amphetamine exposure and may add to this risk. Do not stop an antidepressant abruptly; the prescriber should coordinate any change.

Alkalinizing and acidifying agents

Alkalinizing products can raise amphetamine blood levels and potentiate effects; coadministration should generally be avoided. Acidifying agents such as ascorbic acid can reduce levels. Antacids, bicarbonate, vitamin C, and dietary changes should not be used to manipulate performance.

Caffeine, decongestants, nicotine, and other stimulants

Energy drinks, high-dose coffee, pre-workout powders, stimulant weight-loss products, nicotine, and sympathomimetic decongestants can worsen heart rate, blood pressure, anxiety, tremor, or insomnia. Tell the clinician the real quantity and frequency.

Proton pump inhibitors and antihypertensives

Proton pump inhibitors may alter the time to peak concentration. Amphetamines may reduce the effect of some blood-pressure medicines. The pharmacist should review exact products, including occasional nonprescription use.

Serotonin Syndrome Emergency Dashboard

Serotonin syndrome may include agitation, hallucinations, delirium, confusion, coma, fast heart rate, unstable blood pressure, dizziness, sweating, flushing, fever, tremor, rigidity, muscle twitching, poor coordination, seizures, nausea, vomiting, or diarrhea. A concerning cluster—especially after starting or increasing a serotonergic medicine—requires emergency evaluation under the Medication Guide and clinician’s instructions.

Renal Dashboard: Why Kidney Function Can Change the Dose

Severe renal impairment increases the importance of dose modification. Current labeling recommends 15 mg once each morning for adults with an estimated GFR from 15 to less than 30 mL/min/1.73 m² and 5 mg for pediatric patients ages 6 to 17 with severe impairment, with a 20 mg maximum for children ages 6 to 12 in that category. Adderall XR is not recommended in end-stage renal disease.

Therefore, a 20 mg capsule may be inappropriate for an adult with severe renal impairment even when 20 mg is the usual labeled adult recommendation. Report kidney disease, major dehydration, or laboratory changes to the prescriber.

Pregnancy and Lactation Dashboard

Tell the healthcare professional about pregnancy or plans to become pregnant. Current labeling states that it is not known whether Adderall XR will harm the unborn baby and describes a pregnancy registry for psychostimulant exposure. The clinician should balance maternal ADHD impairment, treatment alternatives, and potential fetal effects.

Amphetamine passes into breast milk. The current Medication Guide advises not breastfeeding during Adderall XR treatment. Discuss feeding and treatment choices with the prescriber; do not make an abrupt independent change.

Dependence and Misuse Dashboard

Physical dependence can develop during prolonged prescribed use. Abrupt stopping or a major dose reduction may cause fatigue, depression or low mood, sleep changes, increased appetite, or other withdrawal symptoms. Any reduction should be directed by the prescriber.

Potential misuse signs include taking 20 mg more than once daily without instructions, using it primarily for energy or appetite suppression, opening capsules to change the effect, repeatedly running out early, obtaining stimulants from several sources, or giving capsules to others. Address these signs promptly and without shame. A safer ADHD and substance-use plan can be developed.

Storage Dashboard: Prevent Diversion and Accidental Use

Store the medicine in the original labeled container at controlled room temperature and protected from light as instructed. Use a locked box or cabinet. Do not leave it in a backpack, car, shared desk, kitchen, dormitory space, handbag, or bathroom cabinet.

When a teenager is prescribed 20 mg, a responsible adult and clinician should decide how access and administration will be managed. Medication security is a health measure, not a statement of distrust. At school, use the authorized medication process rather than sending loose capsules.

Disposal Dashboard

Use a medicine take-back program or DEA-authorized collection site whenever possible. If one is unavailable, current patient instructions advise mixing unused medicine with an undesirable, nontoxic substance such as dirt, cat litter, or used coffee grounds, placing it in a sealed container, and discarding it in household trash. Follow current FDA guidance for the specific product.

Do not retain extra 20 mg capsules for future busy periods, share them, sell them, or place them loose in accessible trash. Remove personal information from the empty pharmacy label.

Pharmacy Dashboard: Buying Adderall XR 20 mg Legally

Searches such as “buy Adderall XR 20 mg online,” “Adderall XR 20 mg prescription,” “generic Adderall XR 20 mg cost,” and “Adderall XR 20 mg pharmacy availability” concern a Schedule II controlled stimulant. A lawful online pharmacy requires a valid prescription and follows federal and state requirements. It should have a verifiable U.S. physical address and telephone number, a licensed pharmacist, and state-board licensure.

Check the pharmacy directly in the state board of pharmacy database. Do not rely solely on a badge displayed by the seller. Avoid any website or social account that offers no-prescription Adderall, sells loose pills, markets “study drugs,” promises anonymous supply, uses implausibly low prices, or lacks a verifiable pharmacist and address.

Counterfeit pills may contain methamphetamine, illicit fentanyl, or another ingredient and can closely resemble a branded product. There is no safe way to verify an unlicensed pill through a photograph or home test alone.

At dispensing, confirm the patient, extended-release formulation, 20 mg strength, manufacturer, imprint, quantity, instructions, and packaging. Call the pharmacist before taking any capsule that is unexpected, damaged, loose, mislabeled, or from a different product.

Price and Supply Dashboard

Current cost varies with pharmacy, location, insurance, deductible, quantity, brand or generic choice, and manufacturer. Inventory also changes. Ask the licensed pharmacy and insurer for a patient-specific estimate and discuss covered alternatives with the prescriber when needed.

During a shortage, do not substitute immediate-release Adderall, two 10 mg capsules, a 15 mg plus 5 mg combination, another stimulant, or someone else’s prescription unless the prescriber issues clear new directions and the pharmacy dispenses the authorized product. Mathematically similar milligrams do not erase formulation and legal differences.

Brand Versus Generic 20 mg Extended-Release Capsules

An FDA-approved generic must meet standards for active ingredient, strength, dosage form, route, quality, and bioequivalence. Capsule shell, color, imprint, and inactive ingredients can vary. A manufacturer change is not automatically unsafe, but it should be verified.

If the response appears different after a change, keep dose time, food, caffeine, sleep, and other variables as consistent as practical; record the pattern; and contact the pharmacist and prescriber. Do not take an extra capsule to compensate. Ask about inactive ingredients when there is a relevant allergy or sensitivity.

Review Dashboard: Questions for the Next Appointment

• Which ADHD-related functional targets improved on 20 mg?
• What time did benefit start and fade on ordinary days?
• Were sleep, appetite, weight, or pediatric growth affected?
• What were the requested pulse and blood-pressure trends?
• Were there mood, psychotic, tic, seizure, or circulation symptoms?
• Did caffeine, nicotine, decongestants, supplements, or new prescriptions complicate the response?
• Were any doses missed, taken late, altered, lost, or used differently than directed?
• Does kidney function require a different strength?
• Should 20 mg be continued, reduced, changed, or discontinued?

Four Checkpoints for a 20 mg Treatment Review

Checkpoint 1: Before the first dose or increase

Record baseline target symptoms, blood pressure and pulse as directed, weight, pediatric height, appetite, usual caffeine and nicotine exposure, and a typical week of sleep. Confirm the complete medicine list and the last dose of the previous strength or formulation. If the patient is moving from 10 mg to 20 mg, clarify exactly when the lower strength ends; do not keep both bottles active without a written plan.

Checkpoint 2: The first several days

Observe administration accuracy and early tolerability. Note severe appetite loss, prolonged insomnia, significant anxiety, marked irritability, palpitations, dizziness, headache, or stomach symptoms. Mild effects still deserve documentation, while emergency signs require immediate care. Do not judge success solely from a burst of energy or unusually intense work—therapeutic benefit should improve regulated, repeatable function.

Checkpoint 3: The end of an ordinary week

Compare several settings and days. For an adult, examine essential work, household, relationship, and driving outcomes. For an adolescent, combine age-appropriate self-report with concise caregiver and school observations. Check whether improvement continues when the task is routine, not only interesting or urgent. Review nutrition, sleep, mood, and any pressure from peers to share the medicine.

Checkpoint 4: The scheduled clinical follow-up

Bring the log, current bottle, remaining quantity, updated medicine list, and questions. The prescriber may continue 20 mg, change non-medication supports, return to a lower dose, select another formulation, or discontinue under supervision. The presence of some residual ADHD symptoms does not automatically support an increase; complete symptom removal may not be realistic, and adverse effects often become more important as exposure rises.

Adult-Specific Considerations at 20 mg

Adults may have hypertension, coronary risk, anxiety, substance use, sleep apnea, or kidney impairment that was not present during earlier stimulant treatment. A childhood diagnosis or old prescription does not replace current screening. Work demands can also encourage misuse through skipped meals, late dosing, excessive caffeine, or extra capsules during deadlines.

Track outcomes outside productivity. Ask whether listening, emotional regulation, financial decisions, household tasks, and safe driving improve. A regimen that permits longer work but worsens sleep, relationships, anxiety, or cardiovascular measures may not provide a favorable overall result. Adults should tell every clinician—including dentists and urgent-care professionals—about the stimulant before receiving interacting medicines.

Adolescent-Specific Considerations at 20 mg

An adolescent who moves to 20 mg needs appetite, weight, height, sleep, mood, tics, blood pressure, pulse, and diversion risk monitored. Encourage honest reporting without making the teenager responsible for choosing the dose. Ask about school bathrooms, sports teams, social media, and peer requests because stimulant sharing can be normalized in some settings.

Medication should not substitute for assessment of learning needs, bullying, family stress, depression, anxiety, or inadequate sleep. If grades do not improve despite better ADHD symptoms, the next step may be educational or psychological support rather than more stimulant. Growth changes, restrictive eating, or body-image-driven use require prompt review.

Travel and Temporary Schedule Changes

Plan travel with the prescriber and pharmacist in advance. Keep Adderall XR in the original labeled container, carry only the patient’s medicine, and review destination rules for controlled stimulants. Do not repackage capsules into an unmarked container or mail them to yourself without verifying applicable requirements.

Time-zone changes can affect the “upon awakening” schedule and sleep. Ask the prescriber or pharmacist for a specific plan rather than taking two doses in a shortened day or using an afternoon capsule. Secure the bottle in lodging and never leave it in checked communal baggage, a rental car, or an unlocked hotel room.

When a 20 mg Prescription Should Be Reassessed Early

Do not wait for a routine appointment when there is clinically significant weight loss, persistent insomnia, repeated high blood pressure or pulse, worsening anxiety, new tics, circulation symptoms, marked emotional change, or no meaningful functional benefit. Reassessment is also important after kidney-function decline, a new pregnancy, a serious illness, or addition of an interacting medicine.

Seek urgent help if the patient is escalating use, purchasing extra capsules, hiding the quantity, using the medicine for euphoria or weight loss, or experiencing strong craving. Call emergency services for chest pain, fainting, seizure, dangerous psychosis or mania, suicidal crisis, suspected overdose, or severe serotonin-syndrome symptoms.

Frequently Asked Questions About Adderall XR 20 mg

Is 20 mg the standard adult dose?

Current FDA labeling lists 20 mg per day as the recommended dose for adults starting treatment or switching from another medication. The prescriber must still individualize treatment and use the lowest effective dose.

Can a teenager take 20 mg?

For ages 13 to 17, labeling starts at 10 mg and allows an increase to 20 mg after one week when symptoms remain inadequately controlled. The treating clinician must decide based on benefit and tolerability.

Is Adderall XR 20 mg the same as Adderall IR 20 mg?

No. Extended-release and immediate-release formulations have different release patterns and directions. Do not substitute them without a new prescriber plan.

Can I open the 20 mg capsule and take half?

No. Although the full contents may be sprinkled on applesauce, the dose of one capsule must not be divided. A lower dose requires the correct prescribed strength.

Can Adderall XR be taken with coffee?

Caffeine can add to jitteriness, fast heart rate, anxiety, and insomnia. Discuss the actual caffeine amount with the clinician rather than assuming a universal safe quantity.

What if 20 mg lasts too long or not long enough?

Track administration, meals, target function, and sleep, then contact the prescriber. Do not alter beads, take a late dose, or add an immediate-release product on your own.

Can I order Adderall XR 20 mg without a prescription?

No legitimate U.S. pharmacy should dispense this Schedule II medicine without a valid prescription. No-prescription offers are unsafe and may supply counterfeit drugs.

What should I do if I accidentally take two capsules?

Call Poison Help at 1-800-222-1222 and follow its instructions, or seek emergency care immediately for symptoms or a severe exposure. Do not wait for symptoms before asking for expert guidance.

Source-Based Patient Resources

• FDA Adderall XR Prescribing Information and Medication Guide
• MedlinePlus Dextroamphetamine and Amphetamine Guide
• FDA State-Licensed Online Pharmacy Verification Guidance

Medical disclaimer: This content is general education, not a diagnosis, prescription, or personal dosing instruction. Use Adderall XR only under a qualified prescriber’s care and follow the current pharmacy label. Call 911 for chest pain, fainting, seizure, severe psychiatric symptoms, suspected overdose, or another emergency.